RecruitingNCT06213090

Patterns of Neurodevelopmental Disorders

Patterns of Disease, Outcomes and Treatment Response in Children With Neurodevelopmental Disorders

Sponsor

Richard Frye

Enrollment

1,000 participants

Start Date

Feb 1, 2024

Study Type

OBSERVATIONAL

Conditions

Epilepsy Autism Spectrum Disorder Neurodevelopmental Disorders Down Syndrome Mitochondrial Encephalomyopathies Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infection Pediatric Acute-Onset Neuropsychiatric Syndrome Cerebral Folate Deficiency

Summary

The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with autism spectrum disorder, cerebral folate deficiency, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Rossignol Medical Center

Phoenix, Arizona, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06213090

Related Trials

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

NCT075638814 locations

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

NCT075941195 locations

Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

NCT045260931 location

Feasibility of a Culturally Adapted Nurse-Led COPE Intervention for Caregivers of Children With Autism Spectrum Disorder

NCT077229491 location

Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

NCT071473091 location